CS330591A3 - Imidazole and benzimidazole derivatives being substituted by indole and benzimidazole - Google Patents
Imidazole and benzimidazole derivatives being substituted by indole and benzimidazole Download PDFInfo
- Publication number
- CS330591A3 CS330591A3 CS913305A CS330591A CS330591A3 CS 330591 A3 CS330591 A3 CS 330591A3 CS 913305 A CS913305 A CS 913305A CS 330591 A CS330591 A CS 330591A CS 330591 A3 CS330591 A3 CS 330591A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- group
- carbon atoms
- compound
- mmol
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60663190A | 1990-10-31 | 1990-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS330591A3 true CS330591A3 (en) | 1992-06-17 |
Family
ID=24428787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS913305A CS330591A3 (en) | 1990-10-31 | 1991-10-31 | Imidazole and benzimidazole derivatives being substituted by indole and benzimidazole |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0488532A1 (fi) |
| JP (1) | JPH0592969A (fi) |
| KR (1) | KR920008032A (fi) |
| CN (1) | CN1061224A (fi) |
| AU (1) | AU650294B2 (fi) |
| CA (1) | CA2054594A1 (fi) |
| CS (1) | CS330591A3 (fi) |
| EG (1) | EG19826A (fi) |
| FI (1) | FI915148A (fi) |
| HU (1) | HU214575B (fi) |
| IE (1) | IE913785A1 (fi) |
| IL (1) | IL99917A0 (fi) |
| MX (1) | MX9101873A (fi) |
| MY (1) | MY108611A (fi) |
| NO (1) | NO180749C (fi) |
| NZ (1) | NZ240383A (fi) |
| PH (1) | PH31175A (fi) |
| PL (1) | PL168902B1 (fi) |
| PT (1) | PT99404A (fi) |
| RO (1) | RO109735B1 (fi) |
| RU (1) | RU2111208C1 (fi) |
| YU (1) | YU173791A (fi) |
| ZA (1) | ZA918688B (fi) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
| GB9113628D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic derivatives |
| GB9113626D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic compounds |
| CA2109932A1 (en) * | 1992-03-25 | 1993-09-30 | Yoshihisa Inoue | Isoindazole compound |
| DK40192D0 (da) * | 1992-03-26 | 1992-03-26 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
| CA2109931A1 (en) * | 1992-03-27 | 1993-10-14 | Hiroshi Matsui | Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor |
| US5538973A (en) * | 1992-03-27 | 1996-07-23 | Kyoto Pharmaceutical Industries, Ltd. | Imidazole derivative, pharmaceutical use thereof, and intermediate therefor |
| GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
| AU675484B2 (en) * | 1993-03-24 | 1997-02-06 | Neurosearch A/S | Benzimidazole compounds, their use and preparation |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| KR20070028553A (ko) | 2004-06-18 | 2007-03-12 | 바이올리폭스 에이비 | 염증 치료에 유용한 인돌 |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US8013006B2 (en) | 2004-07-14 | 2011-09-06 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| EP1781289A1 (en) | 2004-07-22 | 2007-05-09 | PTC Therapeutics, Inc. | Thienopyridines for treating hepatitis c |
| BRPI0519774A2 (pt) | 2005-01-19 | 2009-02-10 | Biolipox Ab | composto ou um sal farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, mÉtodo de tratamento de uma doenÇa em que inibiÇço da atividade de um membro da famÍlia mapeg É desejada e/ou necessÁria, produto combinado, e, processo para a preparaÇço de um composto |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| EP2527360B1 (en) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN103965167A (zh) * | 2013-01-29 | 2014-08-06 | 通化济达医药有限公司 | 咪唑羧酸衍生物 |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
| CN106397414A (zh) * | 2015-08-14 | 2017-02-15 | 陈志龙 | 杂螺环酮吲哚衍生物的一种制备方法 |
| CN113999204B (zh) * | 2021-11-08 | 2023-09-05 | 常州大学 | 一种非手性咪唑型离子化合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826862A (en) * | 1988-02-12 | 1989-05-02 | Janssen Pharmaceutica, N.V. | Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates |
| GB8820231D0 (en) * | 1988-08-25 | 1988-09-28 | Fujisawa Pharmaceutical Co | New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same |
| PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
| DE4010797A1 (de) * | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
-
1991
- 1991-10-23 PH PH43330A patent/PH31175A/en unknown
- 1991-10-29 NZ NZ240383A patent/NZ240383A/en unknown
- 1991-10-30 RO RO148651A patent/RO109735B1/ro unknown
- 1991-10-30 RU SU5010095A patent/RU2111208C1/ru active
- 1991-10-30 EG EG66391A patent/EG19826A/xx active
- 1991-10-30 HU HU913418A patent/HU214575B/hu not_active IP Right Cessation
- 1991-10-30 NO NO914263A patent/NO180749C/no unknown
- 1991-10-30 IE IE378591A patent/IE913785A1/en not_active Application Discontinuation
- 1991-10-31 KR KR1019910019254A patent/KR920008032A/ko active IP Right Grant
- 1991-10-31 AU AU86910/91A patent/AU650294B2/en not_active Ceased
- 1991-10-31 EP EP91310076A patent/EP0488532A1/en not_active Ceased
- 1991-10-31 CA CA002054594A patent/CA2054594A1/en not_active Abandoned
- 1991-10-31 CS CS913305A patent/CS330591A3/cs unknown
- 1991-10-31 PL PL91292249A patent/PL168902B1/pl unknown
- 1991-10-31 MY MYPI9102106 patent/MY108611A/xx unknown
- 1991-10-31 JP JP3286584A patent/JPH0592969A/ja active Pending
- 1991-10-31 YU YU173791A patent/YU173791A/sh unknown
- 1991-10-31 PT PT99404A patent/PT99404A/pt not_active Application Discontinuation
- 1991-10-31 FI FI915148A patent/FI915148A/fi unknown
- 1991-10-31 CN CN91110565A patent/CN1061224A/zh active Pending
- 1991-10-31 IL IL99917A patent/IL99917A0/xx unknown
- 1991-10-31 MX MX9101873A patent/MX9101873A/es not_active IP Right Cessation
- 1991-10-31 ZA ZA918688A patent/ZA918688B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO180749C (no) | 1997-06-11 |
| JPH0592969A (ja) | 1993-04-16 |
| ZA918688B (en) | 1992-08-26 |
| AU650294B2 (en) | 1994-06-16 |
| EG19826A (en) | 1996-03-31 |
| MX9101873A (es) | 1992-06-05 |
| HUT59677A (en) | 1992-06-29 |
| CA2054594A1 (en) | 1992-05-01 |
| YU173791A (sh) | 1994-01-20 |
| CN1061224A (zh) | 1992-05-20 |
| PL168902B1 (pl) | 1996-05-31 |
| NZ240383A (en) | 1994-12-22 |
| IE913785A1 (en) | 1992-05-22 |
| AU8691091A (en) | 1992-05-07 |
| HU214575B (hu) | 1998-04-28 |
| MY108611A (en) | 1996-10-31 |
| IL99917A0 (en) | 1992-08-18 |
| PT99404A (pt) | 1992-09-30 |
| NO914263D0 (no) | 1991-10-30 |
| PL292249A1 (en) | 1992-07-13 |
| NO180749B (no) | 1997-03-03 |
| NO914263L (no) | 1992-05-04 |
| FI915148A0 (fi) | 1991-10-31 |
| EP0488532A1 (en) | 1992-06-03 |
| HU913418D0 (en) | 1992-01-28 |
| FI915148A (fi) | 1992-05-01 |
| RU2111208C1 (ru) | 1998-05-20 |
| KR920008032A (ko) | 1992-05-27 |
| PH31175A (en) | 1998-03-20 |
| RO109735B1 (ro) | 1995-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS330591A3 (en) | Imidazole and benzimidazole derivatives being substituted by indole and benzimidazole | |
| US5374615A (en) | Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives | |
| EP0450566B1 (de) | Substituierte Azole, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung | |
| US5190942A (en) | Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives | |
| US5436260A (en) | Angiotensin II receptor antagonists | |
| US5322950A (en) | Imidazole with angiotensin II antagonist properties | |
| US5378704A (en) | Non-peptidic angiotensin-II-receptor-antagonists | |
| US5191086A (en) | Imidazole and benzimidazole derivatives | |
| SK8402003A3 (en) | Phenylethenyl or phenylethinyl derivatives as glutamate receptor or antagonists | |
| US5208235A (en) | Indole- and benzimidazole-substituted imidazole derivatives | |
| US5212177A (en) | Indole and benzimidazole-substituted dihydropyrimidine derivatives | |
| WO1992004343A1 (en) | Novel tetrahydrobenzazole derivative | |
| FI110512B (fi) | Menetelmä angiotensiini II:n antagonisteina käyttökelpoisten substituoitujen indolien valmistamiseksi | |
| US5208234A (en) | Substituted imidazole phosphonic and phosphinic acid derivatives | |
| SK13195A3 (en) | Imidazole carboxylic acids and pharmaceutical agent containing thereof | |
| SK2895A3 (en) | Substituted 3-cyclobutene-1,2-diones, method of their preparation and pharmaceutical agents which containing thereof | |
| EP0529253A1 (de) | Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| EP0485929A1 (de) | Substituierte Azole, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| SK297692A3 (en) | Imidazolylpropene acid substituted derivatives | |
| EP0501269A1 (en) | Imidazole and benzimidazole derivatives | |
| DE4142366A1 (de) | Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
| US5389661A (en) | Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties | |
| US5234923A (en) | Substitute indole and benzimidazole derivatives | |
| HU217627B (hu) | Eljárás bifenil-szubsztituált kinolin- és naftiridinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására | |
| PT99008A (pt) | Processo para a preparacao de compostos 1,3,5-trisubstituido-1,2,4-triazole para o tratamento de perturbacoes circulatorias |